#lilly

3 stories

#mounjaro #american academy of ophthalmology #capital costs #cardiometabolic #compliance costs #diabetes #earnings reports #eli lilly #fda #federated hermes #financial executives international #foundayo

Eli Lilly Q2 2026 Revenue Surge
Lilly's Mounjaro revenue nearly doubled to $9.94 billion in Q2 2026, driving 48% revenue growth.
Alphastreet - Earnings Decoded. Market Intelligence Delivered · 1m
US Regulators Propose Less Frequent Earnings Reports
SEC wants corporate earnings reports less frequent but investors fear reduced transparency.
The Conversation · 1m
GLP-1 Users Face Rare Vision Loss Risk
GLP-1 drugs may cause rare vision loss, but benefits outweigh risks for most.
ABC7 New York · 1m